Epigenetic BET inhibitor apabetalone counters inflammatory and fibrotic processes in activated cardiac fibroblasts providing insight into reduced hospitalizations for heart failure in BETonMACE trial
30 August 2024 (08:00 - 17:30)
Organised by: 
About the speaker
Calgary (Canada)
5 More presentations in this session
Assistant Professor A. Mengozzi (Pisa, IT)
Doctor S. Costantino (Zurich, CH)
Doctor Z. Qiu (Shanghai, CN)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
You may be interested in
Congress Presentation
Congress Presentation
